Locations:
Collaborative citywide initiative reshapes protocols to boost cardiac arrest survival
For severe cases, complete unroofing of the bridge is imperative
Lower threshold expanded revascularization candidacy without raising early complication rates
Elevated levels of the gut microbial metabolite predict prevalence and adverse outcomes in community-based study
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
They generally depend on the mutated gene, clone size and clinical setting
Large analysis adds to evidence that absolute diameter alone may miss vulnerable patients
Procedure places the center among only a handful worldwide to offer the minimally invasive approach
Phase 1 trial shows up to 97% decrease through 48 weeks with good tolerability
Post hoc ALPACA analysis boosts biological rationale for ongoing outcomes trial of lepodisiran
Durability findings propel potential one-time treatment approach to phase 1b testing
Advertisement
Advertisement
Search